Bulletin
Investor Alert

Illumina Inc.

NAS: ILMN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 27, 2023, 7:59 p.m.

/zigman2/quotes/203509482/composite

$

213.99

Change

-0.04 -0.02%

Volume

Volume 36,293

Quotes are delayed by 20 min

/zigman2/quotes/203509482/composite

Previous close

$ 212.78

$ 214.03

Change

+1.25 +0.59%

Day low

Day high

$207.83

$215.09

Open

52 week low

52 week high

$173.45

$371.16

Open

Susan H. Tousi

Susan H. Tousi is on the board of La Jolla Playhouse, Inc. and BICO Group AB and Chief Commercial Officer at Illumina, Inc.

Ms. Tousi previously was Vice President & GM-Consumer Inkjet Systems at Eastman Kodak Co. and Program Manager-Research & Development at Phogenix Imaging LLC.

Susan H. Tousi received an MBA from the University of California, Los Angeles and an undergraduate degree from The Pennsylvania State University.

Transactions

Date Shares Transaction Value
01/06/2023 500   Disposition at $204.58 per share. 102,290
12/06/2022 500   Disposition at $212.63 per share. 106,315
11/07/2022 500   Disposition at $223.65 per share. 111,825
11/05/2022 721   Derivative/Non-derivative trans. at $217.19 per share. 156,594
10/06/2022 500   Disposition at $216.59 per share. 108,295
06/10/2022 250   Disposition at $214.85 per share. 53,713
02/22/2022 1,808   Derivative/Non-derivative trans. at $319.86 per share. 578,307
02/22/2022 4,561   Derivative/Non-derivative trans. at $0 per share. 0
01/12/2022 800   Disposition at $425 per share. 340,000
12/28/2021 100   Disposition at $387.06 per share. 38,706
12/08/2021 100   Disposition at $375 per share. 37,500
11/05/2021 982   Derivative/Non-derivative trans. at $408.14 per share. 400,794
10/28/2021 100   Disposition at $414.35 per share. 41,435
09/28/2021 100   Disposition at $418.04 per share. 41,804
08/30/2021 300   Disposition at $463.5 per share. 139,050
08/04/2021 1,000   Disposition at $500 per share. 500,000
07/28/2021 300   Disposition at $486.41 per share. 145,923
06/28/2021 300   Disposition at $478.95 per share. 143,685
05/20/2021 500   Disposition at $400 per share. 200,000
05/05/2021 300   Disposition at $381.88 per share. 114,564
04/06/2021 500   Disposition at $423.44 per share. 211,720
04/05/2021 300   Disposition at $386.03 per share. 115,809
03/05/2021 800   Disposition at $402.24 per share. 321,792
02/17/2021 3,178   Derivative/Non-derivative trans. at $494.24 per share. 1,570,695
02/17/2021 6,306   Derivative/Non-derivative trans. at $0 per share. 0
02/17/2021 694   Award at $0 per share. 0
02/09/2021 2,208   Award at $0 per share. 0
02/05/2021 800   Disposition at $431.9 per share. 345,520
01/20/2021 2,500   Disposition at $400 per share. 1,000,000
01/05/2021 300   Disposition at $365.27 per share. 109,581
12/07/2020 200   Disposition at $350 per share. 70,000
12/07/2020 100   Disposition at $348.03 per share. 34,803
12/04/2020 200   Disposition at $350 per share. 70,000
12/01/2020 100   Disposition at $325 per share. 32,500
11/05/2020 1,121   Derivative/Non-derivative trans. at $311.72 per share. 349,439
10/12/2020 200   Disposition at $350 per share. 70,000
10/07/2020 100   Disposition at $325 per share. 32,500
09/09/2020 200   Disposition at $350 per share. 70,000
09/08/2020 100   Disposition at $336 per share. 33,600
08/05/2020 500   Disposition at $400 per share. 200,000
08/05/2020 300   Disposition at $397.4 per share. 119,220
07/20/2020 500   Disposition at $400 per share. 200,000
07/06/2020 300   Disposition at $375 per share. 112,500
05/28/2020 600   Disposition at $375 per share. 225,000
05/20/2020 300   Disposition at $350 per share. 105,000
05/12/2020 600   Disposition at $325 per share. 195,000
02/11/2020 6,920   Derivative/Non-derivative trans. at $296 per share. 2,048,320
02/11/2020 9,969   Derivative/Non-derivative trans. at $0 per share. 0
02/11/2020 4,985   Award at $0 per share. 0
02/05/2020 2,081   Award at $0 per share. 0
01/06/2020 200   Disposition at $325 per share. 65,000
12/06/2019 1,000   Disposition at $325 per share. 325,000
11/05/2019 1,137   Derivative/Non-derivative trans. at $300.87 per share. 342,090

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Kevin Pegels
Chief-Global Operations
Dr. Joydeep Goswami
Chief Financial & Strategy Officer
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Ms. Carissa Rollins
Chief Information Officer
Dr. Phillip G. Febbo
Chief Medical Officer
Ms. Susan H. Tousi
Chief Commercial Officer
Dr. Craig Michael Ciesla
Vice President
Dr. Bryan Crane
Vice President & Head-System Design
Mr. Charles E. Dadswell
Secretary & General Counsel
Ms. Paula Lynn Dowdy
SVP & GM-Commercial Operations, Europe
Ms. Kathryne Reeves
Chief Marketing Officer
Mr. Scott Ericksen
Ms. Sallilyn Schwartz
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer & Senior Vice President
Mr. John Frank
Chief Public Affairs Officer
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Link to MarketWatch's Slice.